# A Case Report of COVID-19 With Tracheobronchial Aspergillosis

## TL;DR

This case report highlights a rare instance of a patient with both COVID-19 and a fungal infection called tracheobronchial aspergillosis, emphasizing the need to consider fungal infections early in the disease.

## Contribution

The novelty lies in documenting a rare co-occurrence of TBA and early-stage COVID-19 without prior immunosuppression.

## Key findings

- A patient with early-stage COVID-19 developed tracheobronchial aspergillosis.
- Combining bronchoscopy, antiviral, and antifungal treatments led to a positive outcome.
- Fungal infections should be considered even in early stages of COVID-19.

## Abstract

The concurrence of COVID-19 and tracheobronchial aspergillosis (TBA) is rarely documented in clinical practice. This report presents a case of TBA in a patient diagnosed with COVID-19 prior to the administration of immunosuppressive agents. This case underscores the necessity of considering fungal infections in patients with COVID-19, even during the early stages of the disease. The combination of timely bronchoscopy, antiviral therapy, and antifungal treatment resulted in favorable therapeutic outcomes for the patient.